Vaccination against Herpes zoster in patients with immune-mediated inflammatory rheumatic diseases: new data

Vaccination against Herpes zoster in patients with immune-mediated inflammatory rheumatic diseases: new data

Patients with immune-mediated inflammatory rheumatic diseases (IIRD) are more likely to develop herpes zoster (HZ) than individuals in the general population. Live attenuated vaccines and inactivated recombinant vaccines with adjuvant are available to prevent the disease and its complications. Live...

Full description

Saved in:

Bibliographic Details
Main Authors:	N. V. Muravyova, B. S. Belov
Format:	Article
Language:	Russian
Published:	IMA-PRESS LLC 2024-08-01
Series:	Современная ревматология
Subjects:	immune-inflammatory rheumatic diseases rheumatoid arthritis systemic lupus erythematosus glucocorticoids janus kinase inhibitors biologic disease-modifying antirheumatic drugs herpes zoster vaccination recombinant adjuvant vaccine
Online Access:	https://mrj.ima-press.net/mrj/article/view/1629
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Herpes zoster virus infection and rheumatic diseases: Current state of the problem
by: D. V. Bukhanova, et al.
Published: (2016-09-01)

Effectiveness of recombinant zoster vaccine in reducing herpes zoster incidence and all-cause mortality among patients with rheumatoid arthritis: a retrospective cohort study of 21,046 individuals from TriNetX U.S. Collaborative NetworkResearch in context
by: Ying-Li Lin, et al.
Published: (2025-07-01)

Current status of immunisation for herpes zoster
by: Anthony Lawrence Cunningham, et al.
Published: (2025-12-01)

Efficacy, reactogenicity, and safety of the adjuvanted recombinant zoster vaccine for the prevention of herpes zoster in Chinese adults ≥ 50 years: A randomized, placebo-controlled trial
by: Diana Alexandra Echeverria Proano, et al.
Published: (2024-12-01)

Cost-effectiveness analysis of herpes zoster vaccination for adults aged 50 years in Zhejiang province, China
by: Fuxing Chen, et al.
Published: (2025-05-01)

Vaccine Prophylaxis of Herpes Zoster In Rheumatic Diseases: Paradigm Revision and New Opportunities
by: G. I. Gridneva, et al.
Published: (2022-08-01)

From Awareness to Action: Addressing Knowledge Barriers and Promoting Herpes Zoster Vaccination in Chinese Rheumatic Disease Patients
by: Yan Geng, et al.
Published: (2025-06-01)

Herpes zoster infection in patients with inflammatory bowel disease
by: Dong Hyun Kim, et al.
Published: (2025-05-01)

The Herpes Zoster Patient Pathway and Gaps in Current Vaccination Guidelines in Southeast Asia: Summary of a Zoster Experts’ Network Scientific Workshop
by: Gyneth Lourdes G. Bibera, et al.
Published: (2024-12-01)

Knowledge, attitudes, and practices of the general population, herpes zoster patients, and dermatologists toward herpes zoster in China: A quantitative cross-sectional survey
by: Chun Chang, et al.
Published: (2024-12-01)

Systemic lupus erythematosus and herpes zoster: Difficulties of curation (description of clinical observations)
by: A. A. Shumilova, et al.
Published: (2024-11-01)

Real-world data on the use of the Shingrix vaccine among patients with inflammatory arthritis and risk of cardiovascular events following herpes zoster
by: Jeffrey R. Curtis, et al.
Published: (2025-05-01)

Real-world effectiveness of recombinant zoster vaccine in self-identified Chinese individuals aged ≥50 years in the United States
by: Ana Florea, et al.
Published: (2024-12-01)

Vaccination in adults at-increased risk of herpes zoster in Canada: insights from a multidisciplinary panel consensus
by: Wayne Ghesquière, et al.
Published: (2025-12-01)

Real-world effectiveness of recombinant herpes Zoster vaccine: a retrospective, cohort study in Japan
by: Satoko Ohfuji, et al.
Published: (2025-08-01)

The Potential Impact of Increased Recombinant Zoster Vaccine Uptake in Older Adults Worldwide
by: Nikolaos Giannelos, et al.
Published: (2025-05-01)

Course and outcomes of COVID-19 in patients with immunoinflammatory rheumatic diseases: Preliminary data from the NIIR/APP-COVID-19 registry and literature review
by: E. L. Nasonov, et al.
Published: (2021-12-01)

Herpes Zoster Vaccination: Insights into Efficacy, Safety, and Guidelines
by: Michał Oleszko, et al.
Published: (2025-04-01)

Breaking the cycle: considerations for a life-course vaccination strategy against varicella-zoster virus
by: Giacomo Casabona, et al.
Published: (2025-12-01)

Characteristics of clinical manifestations and pharmacotherapy in patients with rheumatoid arthritis requiring switching between biologic disease-modifying antirheumatic drugs and Janus kinase inhibitors
by: A. O. Bobkova, et al.
Published: (2024-08-01)

Cytokine Profile in Patients with Herpes Zoster
by: O.V. Volobuieva
Published: (2024-12-01)

The Role of Procalcitonin Test in the Diagnosis of Bacterial Infections in Rheumatic Diseases
by: B. S. Belov, et al.
Published: (2020-05-01)

From Multimorbidity to Network Medicine in Patients with Rheumatic Diseases
by: Winston Gilcrease, et al.
Published: (2024-11-01)

Final analysis of the ZOE-LTFU trial to 11 years post-vaccination: efficacy of the adjuvanted recombinant zoster vaccine against herpes zoster and related complicationsResearch in context
by: Ana Strezova, et al.
Published: (2025-05-01)

Unilateral Laterothoracic Exanthem in an Adult Following Recombinant Zoster Vaccination
by: Xinjin Liu, et al.
Published: (2025-07-01)

The Association Between Herpes Zoster, Antiherpetic Therapies, and Alzheimer’s Disease: A Comprehensive Systematic Review
by: Ali Alghamdi, et al.
Published: (2025-05-01)

A prospective, multi-center post-marketing surveillance cohort study to monitor the safety of the recombinant zoster vaccine in Chinese adults ≥50 years of age
by: Xinghuo Pang, et al.
Published: (2024-12-01)

The public health impact of recombinant herpes zoster vaccination in adults over 50 years in Spain
by: Andrea García, et al.
Published: (2024-12-01)

An Exploratory Investigation of Representations of Herpes Zoster and Adjuvanted Recombinant Herpes Zoster Vaccination in a Sample of Fragile Adults in Italy
by: Francesco De Caro, et al.
Published: (2025-02-01)

Prevalence, incidence, and risk factors for herpes zoster in systemic lupus erythematosus: a systematic review and meta-analysis
by: Hong-Fei Wang, et al.
Published: (2025-08-01)

Global and regional estimates of vaccine-associated herpes zoster and their related vaccines from 1969 to 2023
by: Jinyoung Jeong, et al.
Published: (2025-04-01)

Vaccination coverage, willingness and determinants of herpes zoster vaccine among individuals aged 50 and above in Ningbo, China: A population-based cross-sectional study
by: Yingying Zhu, et al.
Published: (2025-12-01)

Herpes zoster vaccination: Primary care provider knowledge, attitudes, and practices
by: Nikita Stempniewicz, et al.
Published: (2025-12-01)

Vaccination in Aged Care in Australia: A Retrospective Study of Influenza, Herpes Zoster, and Pneumococcal Vaccination
by: Stephen Wiblin, et al.
Published: (2025-07-01)

Methotrexate and immunogenicity of vaccines in patients with rheumatic diseases
by: В. S. Belov, et al.
Published: (2024-04-01)

Targeting age-appropriate adults' vaccine hesitancy to the herpes zoster vaccine in Ningbo, China: A latent profile analysis
by: Jianmei Wang, et al.
Published: (2025-06-01)

Difficult-to-treat rheumatoid arthritis in the clinical practice of a rheumatological hospital. First look
by: A. V. Gordeev, et al.
Published: (2022-05-01)

Awareness and acceptability of herpes zoster vaccination in people living with HIV
by: Christian Motet, et al.
Published: (2025-08-01)

Evaluating the impact of the vaccination prescription program on herpes zoster vaccine coverage in Ningbo, China: An interrupted time series analysis
by: Jianmei Wang, et al.
Published: (2025-12-01)

Herpes zóster en un niño inmunocompetente
by: Paola Andrea Torres, et al.
Published: (2019-08-01)